We are living through a public health crisis the likes of which has not been seen for generations. But we go into this crisis with one key advantage compared to previous generations - our scientific knowledge and capabilities are a major weapon against the virus, and we find ourselves in a race against time to develop effective therapies and preventative treatments. NMR is a key technique that forms a part of the backbone of analytical chemistry which so underpins much of drug discovery, development and manufacturing. This talk highlights the importance of NMR in this process, with particular reference to COVID-19. It focuses mainly on the impact of using NMR for the quality control and release of existing drug molecules which are in shortage for one reason or another due to the pandemic, and on the solutions which can assist in this process. The talk will be aimed at both spectroscopists and non-NMR experts alike.
THURSDAY, August 27, 2021
11:00AM EST | 05:00PM CET
This webinar will be of interest to those looking to extend and improve their analytical capabilities, heads of analytical and chemical R&D, QC and manufacturing, laboratory managers and expert users of complementary technologies. It is especially dedicated to producers of APIs such as Remdesivir, Dexamethasone, Ribavirin, Midazolam, Hydroxychloroquine, Rocuronium Bromide and Azithromycin.
Dr. Gary Sharman
Senior Scientific Director
Dr. Anna Codina
Director Pharmaceutical Business Unit, Bruker BioSpin